CSL, a company that develops and manufactures vaccines and plasma therapies, raised $1.5 billion in AustraliaÆs largest ever overnight placement. The deal was launched on the same day that the company announced that it had signed an agreement to purchase an American competitor, Talecris Biotherapeutics.
The shares were priced at A$36.75 $32.25, or a 5.8% discount to the last...
¬ Haymarket Media Limited. All rights reserved.